Deciphering Low Cardiac Output Syndrome: Insights and Management in Post-Cardiac Surgery
Open Access
- 9 October 2024
- journal article
- research article
- Published by IMR Press in The Heart Surgery Forum
- Vol. 27 (10) , E1237-E1244
Abstract
Low cardiac output syndrome (LCOS) is a dysfunctional state of the heart that often results in decreased cardiac output that is insufficient to meet current metabolic demands. LCOS is typically seen after post-cardiac surgery and is often associated with worsened outcomes and rising hospital costs. As cardiovascular disease becomes more common in an aging population, the prevalence of LCOS will inevitably increase. Understanding the underlying pathophysiology and management is essential to patient outcomes. This is a comprehensive review of the epidemiology, pathophysiology, treatment options, and outcomes of those who develop LCOS after cardiac surgery.Keywords
This publication has 37 references indexed in Scilit:
- Perioperative prophylactic corticosteroids for cardiac surgery in children: A systematic review and meta-analysisAmerican Heart Journal, 2023
- The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendanBiomedicine & Pharmacotherapy, 2022
- Long-term outcome of perioperative low cardiac output syndrome in cardiac surgery: 1-year results of a multicenter randomized trialJournal of Critical Care, 2020
- Pulmonary hypertension and right ventricular remodeling in HFpEF and HFrEFHeart Failure Reviews, 2019
- Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial InfarctionJACC, 2018
- A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and designAmerican Heart Journal, 2016
- Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trialsJournal of Critical Care, 2015
- Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialAmerican Heart Journal, 2015
- Cardiogenic Shock After Primary Percutaneous Coronary Intervention: Effects of Levosimendan Compared with Dobutamine on HaemodynamicsEuropean Journal of Heart Failure, 2006
- Effects of Levosimendan Versus Dobutamine on Inflammatory and Apoptotic Pathways in Acutely Decompensated Chronic Heart FailureThe American Journal of Cardiology, 2006